Mycobacterium tuberculosis (Mtb) infects one-third of the world's population and ranks seventh in terms of global morbidity and mortality. Patients with bilateral pulmonary tuberculosis (TB), cavitary disease, and persistently positive sputum smears pose a special risk for treatment failure and/or relapse. Under HL59832 we treated 11 active pulmonary TB patients with rIFN-gamma aerosol for one month, noting improvements in symptoms, chest radiographs, and declines in inflammatory cytokines. Also, there were striking declines in HIV-1 viral burdens in 5/5 HIV- l/TB coinfected patients. In bronchoalveolar lavage (BAL) cells we observed increased STAT-1 binding and IRF-1 and -9 binding activity post treatment. In preliminary data, we have been able to identify gene clusters induced/repressed in BAL cells by short-term rIFN-gamma aerosol treatment. Our goal is to now demonstrate clinical efficacy of long-term rIFN-gamma aerosol treatment in advanced, cavitary pulmonary TB, where the risk of failure/relapse is unusually high with standard treatment. We propose in Aim 1 a randomized, controlled clininical trial in 64 patients in a NYU/Bellevue - University of Cape Town subcontract using rIFN-gamma aerosol for 4 months in addition to standard treatment compared to standard treatment alone. Endpoints include percent failure/relapse, time to culture Mtb (including negative culture), and change in cavity size/CT-scan findings.
In Aim 2 we will evaluate the Thl response in blood and lung using flow cytometry, cytokine measurements and in vitro TB antigen challenge to characterize macrophage and lymphocyte responses to 4 months rIFN-gamma.
In Aim 3 we will endeavor to determine the molecular effects of aerosolized rIFN-gamma on TGF-beta, its receptor, and Smad signaling molecules, and downstream effectors including collagen, MMP1 and 9, and CTGF using real-time PCR, EMSAs, and immunoblots with Richard Pine, PhD (subcontract to the Public Health Research Institute).
In Aim 3 b we will pursue functional genomics to identify novel human gene targets of rIFN-gamma aerosol and DOTS during the course of treatment. This study is critical in developing efficacious treatment strategies for TB and demonstrating that rIFN-gamma ameliorates the lung fibrosis and destruction in advanced TB.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL059832-08
Application #
6796373
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Peavy, Hannah H
Project Start
1997-09-30
Project End
2007-08-31
Budget Start
2004-09-30
Budget End
2005-08-31
Support Year
8
Fiscal Year
2004
Total Cost
$610,625
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Weiden, Michael D; Hoshino, Satomi; Levy, David N et al. (2014) Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophages. PLoS One 9:e108476
Dawson, Rod; Condos, Rany; Tse, Doris et al. (2009) Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis. PLoS One 4:e6984
Raju, Bindu; Hoshino, Yoshihiko; Belitskaya-Levy, Ilana et al. (2008) Gene expression profiles of bronchoalveolar cells in pulmonary TB. Tuberculosis (Edinb) 88:39-51
Hoshino, Yoshihiko; Hoshino, Satomi; Gold, Jeffrey A et al. (2007) Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis. J Infect Dis 195:1303-10
Katano, Harutaka; Sato, Yuko; Hoshino, Satomi et al. (2007) Integration of HIV-1 caused STAT3-associated B cell lymphoma in an AIDS patient. Microbes Infect 9:1581-9
Achkar, Jacqueline M; Dong, Yuxin; Holzman, Robert S et al. (2006) Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis. Clin Vaccine Immunol 13:1291-3
Tanaka, Naohiko; Hoshino, Yoshihiko; Gold, Jeffrey et al. (2005) Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages. Am J Respir Cell Mol Biol 33:406-11
Raju, Bindu; Hoshino, Yoshihiko; Kuwabara, Kenichi et al. (2004) Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun 72:1275-83
Condos, Rany; Hull, Frank P; Schluger, Neil W et al. (2004) Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis. Chest 125:2146-55
Gold, Jeffrey A; Hoshino, Yoshihiko; Tanaka, Naohiko et al. (2004) Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect Immun 72:645-50

Showing the most recent 10 out of 21 publications